Product Images Medline

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Medline NDC 53329-191 by Medline Industries, Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Step 2 Label - 53329 191

Step 2 Label - 53329 191

This is a Drug Facts label for a nicotine transdermal patch system designed as a stop-smoking aid for individuals who smoke more than 10 cigarettes per day. The active ingredient and dosage information are not available. Warnings advise to consult a doctor before use and to keep the patches out of reach of children. The system comes with a user manual and a behavior support program. The patch is a 24-hour time-release and should be used after completing Step 1. The patches are supplied in child-resistant pouches and should not be used if the individual pouches are open or torn. Inactive ingredients are listed, and there is a section for questions or comments directed to one's healthcare provider. The text includes errors and is not fully understandable.*

Step 1 Label - 53329 192

Step 1 Label - 53329 192

Step 3 Label - 53329 193

Step 3 Label - 53329 193

This is a description of a smoking cessation aid in the form of a clear transdermal nicotine patch that delivers 7mg of nicotine over a 24 hour period. The patch is to be used after completing STEP 2 of the behavioral support program provided with the product. The package contains 14 patches and should not be used if the individual pouches are opened or torn. The purpose of the product is to assist with smoking cessation. There appears to be some errors in the text which may impact the accuracy of the information.*

schedule - patch schedule

schedule - patch schedule

This is a description of a prescription plan for using patches to quit smoking. The plan involves three phases: weeks 1 through 4, weeks 5 and 6, and weeks 7 and 8. During weeks 1 through 4, one 21 mg patch should be used per day. During weeks 5 and 6, one 14 mg patch should be used per day. Finally, during weeks 7 and 8, one 7 mg patch should be used per day.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.